Physician

Gian-Carlo Giove, MD

According to 2025 Medicare claims, Gian-Carlo Giove, MD (NPI: 1700194966) practices advanced heart failure and transplant cardiology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is TALLAHASSEE MEMORIAL HEALTHCARE INC (NPI: 1366293102; TIN: 591917016) and primary practice location at 32308-4646. Giove is affiliated with the CHSPSC ACO 2, LLC (ACO ID: A3664), participating under the MSSP model.

Giove's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,107 traditional Medicare patients, billed 3,085 HCPCS/CPT codes, and received $220,444 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 16,910 prescription claims across 1,366 beneficiaries totaling $14,120,513 in drug costs, led by Opsumit (Macitentan). DME data shows 267 claims. Open Payments data shows 261 records totaling $47,532. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $73,730 and ending at $220,444. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $23,193 to $14,120,513. For DME billing, reported payments rose steadily, from $13,270 to $69,931.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	245	1,005	$73,730
2016	773	3,290	$247,661
2017	736	3,942	$269,968
2018	1,140	4,709	$343,996
2019	1,570	4,613	$346,029
2020	1,288	4,087	$283,637
2021	1,405	4,403	$341,589
2022	1,134	3,309	$230,756
2023	1,149	3,205	$204,924
2024	1,107	3,085	$220,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	104	557	$23,193
2016	253	2,253	$433,386
2017	397	3,694	$809,222
2018	554	5,038	$797,537
2019	704	6,819	$1,178,012
2020	902	9,581	$1,884,823
2021	1,064	12,525	$3,311,162
2022	1,130	13,585	$4,338,145
2023	1,178	14,091	$7,802,307
2024	1,366	16,910	$14,120,513

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	348	$388,006
2017	48	532	$83,320
2018	N/R	548	$37,458
2019	N/R	142	$58,309
2020	N/R	535	$78,472
2021	37	446	$105,416
2022	14	285	$109,766
2023	14	374	$289,494
2024	N/R	267	$74,487

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	122	122	$163
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	115	120	$143
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	234	459	$139
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	418	426	$110
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	380	444	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	279	8,333	$3,568,350
Adempas	Riociguat	168	5,040	$2,339,307
Vyndamax	Tafamidis	94	2,820	$2,116,427
Entresto	Sacubitril/Valsartan	1,034	42,204	$907,690
Jardiance	Empagliflozin	1,009	40,433	$780,352

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	19	$46,469
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	82	$20,019
J2260	Injection, milrinone lactate, 5 mg	N	N/R	85	$6,344
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	81	$1,655

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	256	$38,534	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$8,998	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gian-Carlo Giove, MD?

Tedicare shows public-source Medicare data for Gian-Carlo Giove, MD (NPI 1700194966), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gian-Carlo Giove, MD have ACO affiliation data?

Gian-Carlo Giove, MD is shown with ACO affiliation data for CHSPSC ACO 2, LLC (MSSP, ACO ID A3664).

What billing organization is linked to Gian-Carlo Giove, MD?

Gian-Carlo Giove, MD is linked to TALLAHASSEE MEMORIAL HEALTHCARE INC (billing NPI 1366293102) in the available physician profile data.

Does Gian-Carlo Giove, MD have Open Payments data?

Gian-Carlo Giove, MD has 261 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.